PCM
AMED

Portolan Capital Management’s Amedisys AMED Stock Holding History

Portolan Capital Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-38,286
Closed -$3.71M – 135
2022
Q3 		$3.71M Sell
38,286
-7,300
-16% -$870K 0.39% 89
2022
Q2 		$4.79M Buy
45,586
+28,979
+174% +$3.7M 0.48% 69
2022
Q1 		$2.86M Buy
+16,607
New +$2.48M 0.23% 114

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Portolan Capital Management's AMED Position: Q4 2022 in Review

Portolan Capital Management sold out of Amedisys (AMED) in Q4 2022, closing a stake of 38,286 shares — an estimated $3.71M sold.

Portolan Capital Management first reported a position in AMED in Q1 2022 and held it in 3 quarters. The position peaked at $4.79M in Q2 2022. 277 funds tracked by Wall St. Rank hold AMED as of Q4 2022.

  • Portolan Capital Management reported no remaining Amedisys position as of Q4 2022 after selling out during the quarter.
  • Portolan Capital Management sold 38,286 Amedisys shares in Q4 2022, an estimated $3.71M.
  • Portolan Capital Management first reported a position in Amedisys in Q1 2022 and held it in 3 quarters.
  • Portolan Capital Management's Amedisys position peaked at $4.79M in Q2 2022.
  • 277 funds tracked by Wall St. Rank held Amedisys as of Q4 2022.

Based on Portolan Capital Management's 13F filing for Q4 2022, filed 13 Feb 2023.